Interactive Strength Inc. (Nasdaq: TRNR) to Release Second-Quarter 2025 Results on Thursday, August 14

August 5, 2025 8:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR, FORME and Wattbike brands and pending acquirer of Sportstech, today announced it will release financial results for its second quarter ended June 30, 2025 before the market opens on Thursday, August 14, 2025. Following the filing of its Form 10-Q, the Company as usual will publish a shareholder letter that discusses...

Read more

CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels

August 5, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), a leading innovator in the cannabidiol and wellness product space, is proud to announce a major development in its national expansion strategy, as the company enters the final stages of negotiations for a premium retail location just off the iconic Las Vegas Strip.The targeted location is situated in close proximity to Las Vegas' world-famous resort corridor, offering access to millions of annual tourists,...

Read more

Senzime Secures TetraGraph Installations Across All Sites of World-Leading US Hospital System

August 5, 2025 5:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime today announced another strategic milestone in the U.S., having secured the delivery of its TetraGraph system to all hospital sites within one of the world's top-ranked hospital systems. Following a successful evaluation, the next-generation TetraGraph will be implemented for monitoring both pediatric and adult patients during surgery, including those undergoing robotic procedures. With this latest...

Read more

Will DEA Cole Dismantle Marijuana Research Blockade - MMJ Biopharma Will Be His First Test Case

August 5, 2025 5:00 AM

When President Donald Trump nominated Terrance C. "Terry" Cole to lead the U.S. Drug Enforcement Administration (DEA), it was a clear signal: Cole's primary mission was to dismantle cartels, combat the synthetic opioid crisis, and restore enforcement-first leadership at an agency long mired in political controversy. With a 22-year career at DEA, followed by a successful stint as Virginia's Secretary of Public Safety, Cole embodies the hardened...

Read more

New Scientific Data with TrkA-NAM ACD137 Against Knee Osteoarthritis to be Presented at Pain Conference

August 5, 2025 4:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that an abstract about the preclinical project TrkA-NAM ACD137 against osteoarthritis and other severe pain conditions has been accepted for presentation at the international pain conference NeuPSIG 2025, to be held in Berlin, Germany, September...

Read more

BioNxt Solutions Reports Pending Patent Grants in Europe and Eurasia, Strengthening IP Protection for Proprietary Sublingual Cladribine-Based MS Treatment

August 5, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE: BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to announce significant progress in its global patent portfolio. The Company has received formal communications from both the European Patent Office (EPO) and the Eurasian Patent Organization (EAPO), confirming that the core claims of its patent application covering its...

Read more

American College of Osteopathic Family Physicians Launches New Campaign to Attract Students to Family Medicine

August 4, 2025 5:00 PM

On July 31, the American College of Family Physicians (ACOFP) launched a new campaign, "Family Physicians DO More," at familyphysiciansdomore.org. The campaign is geared towards the needs of high school, undergraduate, and medical school students to help them decide whether osteopathic family medicine is right for them.This campaign is part of a five-year project generously supported by two rounds of funding from the American Board of Family...

Read more

Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement

August 4, 2025 4:05 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce it has entered into a Start-Up Agreement with Avance Clinical Pty Ltd ("Avance"), a leading contract research organization, to initiate key regulatory and clinical documentation, such as the scientific summaries and trial plans required to eventually apply for approvals for human testing, for the Company's lead...

Read more

Waymark Signal Achieves 85% Accuracy in Predicting Medicaid Care Gaps, Study in npj Digital Medicine Shows

August 4, 2025 11:45 AM

Healthcare organizations nationwide face a critical challenge: how to effectively deploy limited staff to close quality measure gaps among patients receiving Medicaid. With health plans facing financial penalties for poor quality performance and providers under value-based contracts unable to reach vulnerable patients through traditional methods, many resort to ineffective and untargeted mass outreach campaigns - helping fewer than 8% of...

Read more

RSLV Aesthetics Redefines Aesthetics Wellness and Weight Loss in Jacksonville Florida

August 4, 2025 10:00 AM

RSLV Aesthetics, located in the heart of Jacksonville, Florida, provides a broad range of non-invasive aesthetic treatments, wellness therapies, and medically guided weight management programs. The clinic integrates modern technologies with individualized care plans to support patient-centered goals in health and appearance. RSLV Aesthetics specializes in customizable services including skin rejuvenation, facial contouring, and body composition...

Read more

Wellness UAE Accelerates Sauna Adoption in Dubai Amid Growing Wellness Movement

August 4, 2025 9:45 AM

WellnessUAE is contributing to Dubai's growing sauna culture as more residents and businesses embrace wellness-focused living. The company offers sauna solutions that combine traditional craftsmanship, modern technology, and restorative design to meet the needs of both residential and commercial spaces.Wellness-Centered Product DesignEach sauna is designed with a focus on relaxation, health benefits, and functional elegance. Heat therapy, when...

Read more

P-n-T Data Corp. Launches Post-n-Track Gen 3 to De-Risk Healthcare Data Sharing and Residency

August 4, 2025 9:10 AM

P-n-T Data Corp., a provider of managed services for healthcare data sharing, today announced the launch of Post-n-Track Gen 3, the next-generation of the company's data service that enables secure, private, and uninterrupted healthcare data sharing while helping eliminate unnecessary PHI/PII exposure, data residency, and costly operational disruptions.Post-n-Track Gen 3 is built for healthcare organizations including payers, providers, TPAs,...

Read more

STEEMCC Initiative to Transform Care Coordination and Behavioral Health Access in the Virgin Islands

August 4, 2025 9:00 AM

The St. Thomas East End Medical Center Corporation (STEEMCC) has announced the launch of the REACH-USVI initiative, which aims to advance resilient behavioral health integration in the US Virgin Islands. The transformative effort is designed to improve outcomes for underserved populations and address critical gaps in care coordination by fostering collaboration among providers, community organizations, and stakeholders across the healthcare...

Read more

CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)

August 4, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with organ transplant rejection and autoimmune diseases, today announced FDA clearance of an IND application for CID-103, an anti-CD38 monoclonal antibody in adults with active and chronic active renal allograft antibody mediated rejection (AMR). The Phase 1 clinical trial is a dose-ranging and safety study...

Read more

Duly Health and Care Opens New Multi-Specialty Clinic in Schaumburg

August 4, 2025 9:00 AM

Duly Health and Care, through one of its medical groups, today announced the official opening of its new 100,000-square-foot clinic at 1325 Meacham Road in Schaumburg, offering personalized, physician-led care across a wide range of specialties, all in one convenient location.Duly created this clinic to meet a critical need in the area, as the majority of Schaumburg residents currently leave the village to access care, relying heavily on...

Read more

Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production

August 4, 2025 8:00 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, announced that the MODD1 cartridge line has been validated for human-use production in the United States."This is an important milestone for scaling up our manufacturing infrastructure to...

Read more

CarePayment Recognized as #1 Patient Financing Vendor in Black Book's 2025 Revenue Cycle Management Rankings

August 4, 2025 8:00 AM

CarePayment, a leading provider of patient financing solutions, has been named the top vendor for patient financing and medical loan solutions in Black Book's comprehensive 2025 Revenue Cycle Management (RCM) software and services rankings for a third consecutive year. The independent evaluation, based on a detailed survey conducted from Q4 2024 through Q3 2025, highlights CarePayment's exceptional performance across critical client satisfaction...

Read more

Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes

August 4, 2025 8:00 AM

The Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of Mass General Brigham, MIT, and Harvard (the Ragon Institute), and IAVI are pleased to announce that the first doses of an investigational HIV vaccine candidate have been administered. The vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1), was first administered on July 28, 2025, at the Mutala Trust clinical trial site in Harare, Zimbabwe....

Read more

Healthcare Leaders Address Economic, Regulatory, and Sustainability Challenges Ahead of AHRMM25

August 3, 2025 1:00 PM

With global economic volatility, workforce dislocation, and intensifying regulatory mandates, U.S. healthcare organizations are under mounting pressure to modernize their supply chain and materials management systems. Black Book Research's latest report, timed ahead of AHRMM25, provides a comprehensive snapshot of how providers are responding to these challenges and identifies the strategic KPIs guiding 2025 vendor evaluations.Survey Overview...

Read more

Top Client-Rated Healthcare Supply Chain Tech Vendors Announced Ahead of AHRMM25 Conference

August 3, 2025 12:30 PM

Black Book Research today announces the top-performing supply chain management technology vendors in U.S. healthcare for 2025. Released ahead of the opening of AHRMM25, the industry's leading healthcare supply chain conference, the results are drawn from the firm's independent, crowdsourced survey of 1,744 validated participants across 1,036 provider organizations.This year's 12th annual Black Book survey focused on vendor performance across 30...

Read more